<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="hwp">eLife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">06074</article-id><article-id pub-id-type="doi">10.7554/eLife.06074</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Structural Biology and Molecular Biophysics</subject></subj-group></article-categories><title-group><article-title>Autoinhibition of Bruton's tyrosine kinase (Btk) and activation by soluble inositol hexakisphosphate</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-22979"><name><surname>Wang</surname><given-names>Qi</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>Howard Hughes Medical Institute, University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23431"><name><surname>Vogan</surname><given-names>Erik M</given-names></name><aff><institution>Beryllium Inc</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23432"><name><surname>Nocka</surname><given-names>Laura M</given-names></name><aff><institution content-type="dept">Department of Chemistry</institution>, <institution>University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-23433"><name><surname>Rosen</surname><given-names>Connor E</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>Howard Hughes Medical Institute, University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-29287"><name><surname>Zorn</surname><given-names>Julie A</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>Howard Hughes Medical Institute, University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-2915"><name><surname>Harrison</surname><given-names>Stephen C</given-names></name><aff><institution content-type="dept">Laboratory of Molecular Medicine</institution>, <institution>Harvard Medical School, Howard Hughes Medical Institute</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-1018"><name><surname>Kuriyan</surname><given-names>John</given-names></name><aff><institution content-type="dept">Department of Molecular and Cell Biology</institution>, <institution>Howard Hughes Medical Institute, University of California, Berkeley</institution>, <addr-line><named-content content-type="city">Berkeley</named-content></addr-line>, <country>United States</country><email>jkuriyan@mac.com</email></aff><xref ref-type="fn" rid="conf3"/></contrib></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-21020"><name><surname>Cole</surname><given-names>Philip A</given-names></name><role>Reviewing editor</role><aff><institution>Johns Hopkins University School of Medicine</institution>, <country>USA</country></aff></contrib></contrib-group><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>02</month><year>2015</year></pub-date><volume>4</volume><elocation-id>e06074</elocation-id><supplementary-material><ext-link xlink:href="elife-06074-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material><history><date date-type="received"><day>13</day><month>12</month><year>2014</year></date><date date-type="accepted"><day>19</day><month>02</month><year>2015</year></date></history><permissions><copyright-statement>Â© 2015, Wang et al</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Wang et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><abstract><p>Bruton's tyrosine kinase (Btk), a Tec-family tyrosine kinase, is essential for B-cell function. We present crystallographic and biochemical analyses of Btk, which together reveal molecular details of its autoinhibition and activation. Autoinhibited Btk adopts a compact conformation like that of inactive c-Src and c-Abl. A lipid-binding PH-TH module, unique to Tec kinases, acts in conjunction with the SH2 and SH3 domains to stabilize the inactive conformation. In addition to the expected activation of Btk by membranes containing phosphatidylinositol triphosphate (PIP<sub>3</sub>), we found that inositol hexakisphosphate (IP<sub>6</sub>), a soluble signaling molecule found in both animal and plant cells, also activates Btk. This activation is a consequence of a transient PH-TH dimerization induced by IP<sub>6</sub>, which promotes transphosphorylation of the kinase domains. Sequence comparisons with other Tec-family kinases suggest that activation by IP<sub>6</sub> is unique to Btk.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group></article-meta></front><back><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Stephen C Harrison, Reviewing editor, eLife.</p></fn><fn fn-type="conflict" id="conf3"><p>John Kuriyan, Senior editor, eLife.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></back></article>